NCT02755090

Brief Summary

This study is a multi-site, double-blinded, randomized, non-inferiority clinical trial of inhaled nitrous oxide with oxygen (N2O/O2) versus intravenous (IV) sedation, with fentanyl and midazolam, for pain management in adult women having a pregnancy termination procedure between 12 and 16 weeks gestational age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 28, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
5 months until next milestone

Results Posted

Study results publicly available

September 15, 2017

Completed
Last Updated

September 15, 2017

Status Verified

July 1, 2017

Enrollment Period

10 months

First QC Date

April 20, 2016

Results QC Date

June 15, 2017

Last Update Submit

August 17, 2017

Conditions

Keywords

nitrouspain

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale (VAS) Score for Maximum Procedural Pain

    To compare women's maximum procedural pain measured on a visual analog scale (VAS) during a surgical abortion between 12 weeks 0 days to 16 weeks 0 days gestational age between women randomized to nitrous oxide versus intravenous sedation. A score of 0 represents no pain and a score of 100 represents pain as bad as it could be.

    Assessed immediately following completion of the procedure (as defined as removal of the speculum)

  • Satisfaction With Anesthesia (Iowa Satisfaction With Anesthesia Scale [ISAS])

    The Iowa Satisfaction with Anesthesia Scale (ISAS) was given to women following a surgical abortion. The ISAS score is the mean of 11 responses to questions regarding satisfaction with anesthesia and has a score range of -3 (disagree strongly) to 3 (agree strongly).

    Assessed 30 minutes after procedure completion.

Study Arms (2)

Nitrous oxide and IV saline

EXPERIMENTAL

Participants in the nitrous oxide group will receive a scented face mask through which nitrous oxide will be administered. The nitrous content of the gas will be titrated up by 20% every 5 breaths with a goal of 70% N2O/ 30% O2 as tolerated by the participant. This group will also receive saline through an IV. All participants will receive local anesthesia in the form of a paracervical block and ibuprofen pre-operatively.

Drug: Nitrous OxideDrug: IV Saline

Standard Care (IV Sedation and Oxygen)

NO INTERVENTION

Within the IV sedation group, women will receive 100mcg fentanyl and 2mg midazolam at least two minutes prior to initiation of the procedure. This group will also receive 100% oxygen by a scented face mask. All participants will receive local anesthesia in the form of a paracervical block and ibuprofen pre-operatively.

Interventions

Participants in the nitrous oxide group will receive a scented face mask through which nitrous oxide will be administered. The nitrous content of the gas will be titrated up by 20% every 5 breaths with a goal of 70% N2O/ 30% O2 as tolerated by the participant. This group will also receive saline through an IV. All participants will receive local anesthesia in the form of a paracervical block and ibuprofen pre-operatively.

Nitrous oxide and IV saline
Nitrous oxide and IV saline

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • pregnancy termination at gestational age of 12-16 weeks
  • able to read and understand either English or Spanish
  • able to obtain reliable post-procedure transportation

You may not qualify if:

  • contraindications to outpatient pregnancy termination
  • contraindications to nitrous oxide use (such as pernicious anemia, current treatment with bleomycin chemotherapy, active upper respiratory illness, or COPD)
  • intrauterine fetal demise
  • chronic narcotic use
  • known adverse reaction to nitrous oxide, Fentanyl, or Versed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Colorado

Denver, Colorado, 173364, United States

Location

University of New Mexico Health Sciences Center

Albuquerque, New Mexico, 87131, United States

Location

Related Publications (1)

  • Thaxton L, Pitotti J, Espey E, Teal S, Sheeder J, Singh RH. Nitrous Oxide Compared With Intravenous Sedation for Second-Trimester Abortion: A Randomized Controlled Trial. Obstet Gynecol. 2018 Nov;132(5):1192-1197. doi: 10.1097/AOG.0000000000002915.

MeSH Terms

Conditions

Pain

Interventions

Nitrous OxideSodium Chloride

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen CompoundsChloridesHydrochloric AcidChlorine CompoundsSodium Compounds

Results Point of Contact

Title
Sharla Biefeld Research Coordinator
Organization
University of New Mexico

Study Officials

  • Rameet Singh, MD, MPH

    University of New Mexico Health Sciences Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Division of Family Planning

Study Record Dates

First Submitted

April 20, 2016

First Posted

April 28, 2016

Study Start

July 1, 2016

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

September 15, 2017

Results First Posted

September 15, 2017

Record last verified: 2017-07

Locations